SCHEMBL2127965

SCHEMBL2127965

COc1ccc(I)c(SCc2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 5/20 0.49
CYP2C8 P10632 5/20 0.49
CYP2D6 P10635 5/20 0.49
CYP2C9 P11712 5/20 0.49
CYP2B6 P20813 5/20 0.49
CYP2C19 P33261 5/20 0.49
MAPT P10636 3/20 0.49
KMT2A Q03164 3/20 0.49
NPC1 O15118 2/20 0.49
ALDH1A1 P00352 2/20 0.49
RAB9A P51151 2/20 0.49
TP53 P04637 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2802030 0.81 CYP2E1 (0.49) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL13065956 0.81 CYP2E1 (0.49) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL29202305 0.81 ALDH1A1 (0.49) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL13024489 0.79 NPC1 (0.53) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL13065957 0.78 CYP2E1 (0.49) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL22492226 0.78 ALDH1A1 (0.49) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL17782927 0.78 MAOB (0.58) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL8484733 0.77 ALDH1A1 (0.49) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL2129699 0.77 CYP2E1 (0.45) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6
SCHEMBL27361821 0.75 TSHR (0.45) CYP2E1CYP2C8CYP2D6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170020840-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LTD (AU) 2017-01-26 US disclosed
US-9346842-B2 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors BIONOMICS LIMITED (AU) 2016-05-24 US disclosed
US-20140171642-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LIMITED (AU) 2014-06-19 US disclosed
US-8716335-B2 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors BIONOMICS LIMITED (AU) 2014-05-06 US disclosed
US-8680135-B2 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors BIONOMICS LIMITED (AU) 2014-03-25 US disclosed
US-20130053351-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LIMITED (AU) 2013-02-28 US disclosed
US-20120214770-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LIMITED (AU) 2012-08-23 US disclosed
US-8198466-B2 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors BIONOMICS LIMITED (AU) 2012-06-12 US disclosed
EP-2460793-A1 Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles And Their Use as Tubulin Polymerisation Inhibitors Bionomics Limited (AU) 2012-06-06 EP disclosed
EP-1984333-B1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LTD (AU) 2012-04-25 EP disclosed
US-20100004208-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LIMITED (AU) 2010-01-07 US disclosed
EP-1984333-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS Bionomics Limited (AU) 2008-10-29 EP disclosed
EP-1363880-A4 SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS UNIV AUSTRALIAN (AU) 2008-10-08 EP disclosed
WO-2007087684-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS BIONOMICS LIMITED (AU) 2007-08-09 WO disclosed
US-20050130221-A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2005-06-16 US disclosed
EP-1363880-A1 SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2003-11-26 EP disclosed
WO-2002060872-A1 SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2002-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214770-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS TUBB1, TUBB3, TUBB CYP2E1 3066/4885CYP2C8 2719/4885CYP2D6 2603/4885
US-20170020840-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS TUBB1, TUBB3, TUBB CYP2E1 3066/4885CYP2C8 2719/4885CYP2D6 2603/4885
US-20100004208-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS TUBB1, TUBB3, TUBB CYP2E1 3066/4885CYP2C8 2719/4885CYP2D6 2603/4885
US-20050130221-A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents TUBB, TUBB3, TUBB1 CYP2E1 4515/4885CYP2C8 3999/4885CYP2D6 3365/4885
US-20140171642-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS TUBB1, TUBB3, TUBB CYP2E1 3066/4885CYP2C8 2719/4885CYP2D6 2603/4885
US-20130053351-A1 SUBSTITUTED BENZOFURANS, BENZOTHIOPHENES, BENZOSELENOPHENES AND INDOLES AND THEIR USE AS TUBULIN POLYMERISATION INHIBITORS TUBB1, TUBB3, TUBB CYP2E1 3066/4885CYP2C8 2719/4885CYP2D6 2603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.